Patents by Inventor Robert A. Blake

Robert A. Blake has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8679763
    Abstract: Human EEF2K genes are identified as modulators of the PTEN/AKT pathway and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT comprising screening for agents that modulate the activity of EEF2K are provided.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: March 25, 2014
    Assignee: Exelixis, Inc.
    Inventors: Arthur Brace, Robert A. Blake, Lori S. Friedman, Lynn Margaret Bjerke, Kevin M. Ward, Susana Nieto-Bergman
  • Publication number: 20110135629
    Abstract: Human MPTENAKT genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of MPTENAKT are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: June 9, 2011
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake
  • Publication number: 20100183583
    Abstract: Human GALK1 genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of GALK1 are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: July 22, 2010
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake
  • Publication number: 20100122354
    Abstract: Human CDC6 genes are identified as modulators of the PTEN/AKT pathway, and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT, comprising screening for agents that modulate the activity of CDC6 are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: May 13, 2010
    Applicant: EXELIXIS, INC.
    Inventors: Arthur Brace, Margaret Lynn Bjerke, Susana Nieto-Bergman, Lori S. Friedman, Kevin Ward, Robert A. Blake
  • Publication number: 20080226154
    Abstract: Systems and methods for producing a carbonaceous paste are provided. The systems and methods may include a paste control system that obtains an image of the carbonaceous paste and determines whether operational parameters associated with paste production require adjustment. One or more operational variables may be adjusted based on the obtained images to facilitate production of the carbonaceous paste.
    Type: Application
    Filed: March 11, 2008
    Publication date: September 18, 2008
    Applicant: Alcoa Inc.
    Inventors: Jay N. Bruggeman, Angelique Adams, David Coleman, Robert A. Blake
  • Publication number: 20080193438
    Abstract: Human EEF2K genes are identified as modulators of the PTEN/AKT pathway and thus are therapeutic targets for disorders associated with defective PTEN/AKT function. Methods for identifying modulators of PTEN/AKT comprising screening for agents that modulate the activity of EEF2K are provided.
    Type: Application
    Filed: March 10, 2006
    Publication date: August 14, 2008
    Applicant: EXELIXIS INC.
    Inventors: Arthur Brace, Robert A. Blake, Lori S. Friedman, Lynn Margaret Bjerke, Kevin M. Ward, Susana Nieto-Bergman
  • Patent number: 7337672
    Abstract: This invention discloses a method of evaluating the internal structure of a grinding wheel through ultrasonic inspection.
    Type: Grant
    Filed: July 8, 2005
    Date of Patent: March 4, 2008
    Assignee: Alcoa Inc.
    Inventors: Robert A. Blake, Neville Whittle, Michelle M. Teichman
  • Publication number: 20040266855
    Abstract: The present invention relates to certain 3-(4,5,6,7-tetrahydroindol-2-yl-methylidene)-2-indolinone derivatives that inhibit kinases, in particular Src kinase. Pharmaceutical compositions comprising these compounds, methods of treating diseases mediated by kinases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing them are also disclosed.
    Type: Application
    Filed: July 13, 2004
    Publication date: December 30, 2004
    Applicant: SUGEN, INC.
    Inventors: Congxin Liang, Huiping Guan, Peng Cho Tang, Robert A. Blake
  • Patent number: 6777417
    Abstract: The present invention relates to certain 3-(4,5,6,7-tetrahydroindol-2-yl-methylidene)-2-indolinone derivatives that inhibit kinases, in particular Src kinase. Pharmaceutical compositions comprising these compounds, methods of treating diseases mediated by kinases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing them are also disclosed.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: August 17, 2004
    Assignee: Sugen, Inc.
    Inventors: Congxin Liang, Huiping Guan, Peng Cho Tang, Robert A. Blake
  • Publication number: 20030119819
    Abstract: The present invention relates to certain 3-(4,5,6,7-tetrahydroindol-2-yl-methylidene)-2-indolinone derivatives that inhibit kinases, in particular Src kinase. Pharmaceutical compositions comprising these compounds, methods of treating diseases mediated by kinases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing them are also disclosed.
    Type: Application
    Filed: September 10, 2002
    Publication date: June 26, 2003
    Applicant: Sugen, Inc.
    Inventors: Congxin Liang, Huiping Guan, Peng Cho Tang, Robert A. Blake
  • Patent number: 6114371
    Abstract: The present invention relates to novel 3-(cyclohexano-heteroarylidenyl)-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which are expected to modulate the activity of protein tyrosine kinases and therefore to be useful in the prevention and treatment of protein tyrosine kinase related cellular disorders such as cancer.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: September 5, 2000
    Assignee: Sugen, Inc.
    Inventors: Peng Cho Tang, Li Sun, Gerald McMahon, Robert A. Blake
  • Patent number: 4766794
    Abstract: A radial saw blade is formed of a flat disc having peripheral edge including circular peripheral portions and recessed stepped peripheral portions. The peripheral edge includes spaced apart, radially inwardly extending notches. Each notch has a flat, plate-like insert brazed to an L-shaped seat in the notch facing the direction of rotation. Each insert has cutting edges formed on side edges of the inserts which extend axially from both sides of the disc and on a crown edge extending radially from the peripheral edge of the disc. The side and crown edges each have beveled surfaces extending away from the direction of rotation to define a relief angle. A first set of the notches are positioned about the circular peripheral portion of the peripheral edge. The inserts in the first set of notches make the primary cut in both linear and non-linear passes.
    Type: Grant
    Filed: August 25, 1986
    Date of Patent: August 30, 1988
    Inventor: Robert A. Blake